Xuzhou Medical University

Company snapshot

Xuzhou Medical University ([simplified Chinese](en.wikipedia.org/wiki/Simplified_Chinese): 徐州医科大学; [traditional Chinese](en.wikipedia.org/wiki/Traditional_Chines): 徐州醫科大學; [pinyin](en.wikipedia.org/wiki/Pinyin): Xúzhōu Yīkē Dàxué) is a provincial [medical university](en.wikipedia.org/wiki/Medical_university) located in [Xuzhou](en.wikipedia.org/wiki/Xuzhou), [Jiangsu](en.wikipedia.org/wiki/Jiangsu

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Xuzhou Medical University. Not investment advice.

• What is Xuzhou Medical University?

  Xuzhou Medical University is a pharma organization headquartered in CN. Primary therapeutic focus areas include Balanced Anesthesia. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and

• Is Xuzhou Medical University publicly traded?

  Xuzhou Medical University appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Xuzhou Medical University develop or market?

  We link 4 drug profile(s) where Xuzhou Medical University is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/medical-developments-international-limited#company-drugs.

• What are the latest developments for Xuzhou Medical University?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Xuzhou Medical University focus on?

  Xuzhou Medical University focuses on Balanced Anesthesia based on our analysis of their pipeline programs and drug development activities.